14th Annual Biomarkers Congress is organized by Oxford Global Marketing Ltd and will be held from Feb 21 - 22, 2019 at Manchester Central Convention Complex, Manchester, England, United Kingdom.
The target audience for this medical event is designed for senior level attendees from leading pharmaceutical, biotechnology, diagnostics, CRO and solution provider companies, alongside highly esteemed members of academic research institutions.
The co-located 6th Annual Biomarker in Clinical Development Congress provides a great opportunity for attendees to learn more about the latest status updates about the ever-changing regulatory landscape in clinical development, genomic approaches in drug development, RNAseq NGS in biomarker benchmarking and the advances made in NGS techniques in liquid biopsy. Hear the latest challenges and opportunities in the role of biomarkers in clinical development, clinical trials and clinical diagnostics including implementing clinical biomarkers in auto-immune diseases such as cardiovascular, COPD, immuno-oncology, inflammatory and PK/PD biomarkers to clinical biomarkers.
Course Objectives :
• Biomarkers in Drug Discovery & Development Therapeutic Areas: Autoimmune, Immuno-oncology, Neuroscience, Oncology, Precision Medicine, Companion Diagnostics, Molecular Diagnostics Development.
• Biomarkers in Drug Discovery & Development Therapeutic Areas: Cardiovascular, Rheumatology, Respiratory, COPD, Rare Diseases, Infectious Diseases, Inherited Diseases.
• Innovations in Biomarkers Research, Assay Development, Imaging, Data Integration Methods, Bioinformatics, Trial Design Biomarker: Clinical Development & Clinical Trials.
• Innovative Biology- NGS & Genomic Markers, Clinical Testing and Diagnostics Development.
Additional details will be posted as soon as they are available.
|Contact No.||:||+44 (0)1865 248455|
Conference Fee Details
|Early Fee Last date||:||NA|